TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Svenska Bioforce, AB
Closing information (x1000 EUR)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
3,849
|
3,599
|
4,191 |
| Financial expenses |
48
|
17
|
6 |
| Earnings before taxes |
-250
|
-103
|
151 |
| EBITDA |
-184
|
-68
|
170 |
| Total assets |
3,170
|
2,495
|
2,508 |
| Current assets |
3,116
|
2,439
|
2,481 |
| Current liabilities |
843
|
572
|
743 |
| Equity capital |
832
|
1,042
|
1,264 |
| - share capital |
291
|
280
|
309 |
| Employees (average) |
8
|
8
|
7 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
26.2%
|
41.8%
|
50.4% |
| Turnover per employee |
481
|
450
|
599 |
| Profit as a percentage of turnover |
-6.5%
|
-2.9%
|
3.6% |
| Return on assets (ROA) |
-6.4%
|
-3.4%
|
6.3% |
| Current ratio |
369.6%
|
426.4%
|
333.9% |
| Return on equity (ROE) |
-30.0%
|
-9.9%
|
11.9% |
| Change turnover |
114
|
-198
|
-39 |
| Change turnover % |
3%
|
-5%
|
-1% |
| Chg. No. of employees |
0
|
1
|
1 |
| Chg. No. of employees % |
0%
|
14%
|
17% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.